STAT+: Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports
Top of the morning to you, and a fine one it is. Sunny skies and delicious cool breezes are enveloping the Pharmalot campus this morning, where the birds are chirping, the insects are flitting, and the official mascot is snoozing. This provides an opportunity to fire up the trusty coffee kettle and brew a few cups of stimulation. Today we fancy salted caramel mocha. And what are you having? While you made a decision, dig in to the latest items of interest. A little stimulation is a good thing, yes? Have a great day and do keep in touch …
Johnson & Johnson (JNJ) said that a large, global study showed its Covid-19 vaccine is more effective when given as a two-dose regimen, and that other data indicate the efficacy of the vaccine does not wane, STAT writes. The two-dose regimen prevented 75% of moderate to severe Covid cases in all countries where it was tested — and 94% of such cases in the U.S., where the vaccine probably had to grapple with fewer variants of the virus. Importantly, the two-dose regimen was 100% effective against severe disease.
Continue to STAT+ to read the full story…
